Executive Director, Global Medical Expert HIV Prevention - GMA Virology & Inflam

At Gilead, we’re creating a healthier world for all people. For more than 35 years, we’ve tackled diseases such as HIV, viral hepatitis, COVID-19 and cancer – working relentlessly to develop therapies that help improve lives and to ensure access to these therapies across the globe. We continue to fight against the world’s biggest health challenges, and our mission requires collaboration, determination and a relentless drive to make a difference.Every member of Gilead’s team plays a critical role in the discovery and development of life-changing scientific innovations. Our employees are our greatest asset as we work to achieve our bold ambitions, and we’re looking for the next wave of passionate and ambitious people ready to make a direct impact.We believe every employee deserves a great leader. People Leaders are the cornerstone to the employee experience at Gilead and Kite. As a people leader now or in the future, you are the key driver in evolving our culture and creating an environment where every employee feels included, developed and empowered to fulfil their aspirations. Join Gilead and help create possible, together. Job DescriptionExecutive Director, Global Medical Expert HIV Prevention - GMA Virology & InflammationCompanyGilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, South America, Europe, Asia and Australia. We have the following exciting opportunity in our Global Medical Affairs Virology & Inflammation (GMAVI) organization.Overall ResponsibilitiesReporting to the Vice President and Head of GMAVI, theExecutive Director, Global Medical Expert (GME) – HIV Prevention serves as a senior medical leader and subject matter expert with primary accountability for advancing US HIV Prevention strategy, with a particular focus on accelerating PrEP expansion in priority populations and prioritized provider settings. This includes educating providers around the direct linkage between HIV & STI testing and the barriers to implementing PrEP into current clinic workflows.The role provides scientific leadership across Medical Affairs, shaping external scientific dialogue, consensus development, and medical strategy to support Gilead’s HIV prevention portfolio across current and future modalities. The Executive Director acts as a visible external thought leader and internal strategic partner, translating complex scientific, clinical, and implementation insights into actionable medical strategy.The role operates across the HIV continuum, with approximately 70% focus on HIV Prevention and 30% on HIV Treatment, ensuring coherent medical narratives across prevention, early diagnosis, and treatment. The position is US focused, with accountability for US medical priorities (70%) and selective engagement with global stakeholders (30%) as relevant.Specific Job RequirementsServe as a medical thought leader for PrEP adoption and persistence, advancing evidence‑based approaches to initiation, continuation, re‑initiation, and discontinuation management in real‑world settings. Provide senior medical leadership on the integration of PrEP into routine clinical workflows, including protocolization across priority provider settings (eg, primary care, STI clinics, women’s health, FQHCs, addiction services) Support the US medical strategy for simplified, stepwise PrEP implementation approaches, ensuring scientific accuracy while addressing real‑world feasibility in time‑constrained clinical environments. Support medical field engagement models for PrEP expansion, including alignment across PSEs, RMEs, and matrix partners, to ensure consistent, compliant, and high‑impact scientific exchange. Translate insights from field engagement, advisory boards, and educational programs into iterative refinement of US HIV Prevention medical strategy, with a focus on improving uptake, persistence, and equity. Provide senior medical input into community‑based and implementation science partnerships, with a focus on addressing unmet need and health equity in priority US populations. Support US medical strategy for long‑acting PrEP and future prevention modalities, ensuring readiness across clinical, educational, and implementation dimensions Partner with cross‑functional medical teams to translate real‑world evidence and insight generation into actionable strategy addressing uptake, persistence, and access gaps Contribute to the integration of HIV prevention and treatment medical narratives, ensuring scientific consistency across the care continuum. Act as a visible external scientific ambassador in priority US forums, representing Gilead with credibility, balance, and compliance. Lead advanced scientific exchange on nuanced HIV prevention topics, providing expe